Abstract
It is well-known that cardiac hypertrophy and arterial and renal dysfunction are serious complications of hypertension. Therefore, we investigated the chronic effects of 606A (2-propyl-3-[2'(1H-tetrazole-5-yl)biphenyl-4-yl]methyl-5-acetyl-4,5,6,7- tetrahydro imidazo [4,5-c]pyridine-4-carboxylic acid disodium salt), a novel AT1-receptor antagonist, on these complications of hypertension in stroke-prone spontaneously hypertensive rats (SHRSP) using Wistar Kyoto rats (WKY) as the control. After 8 weeks treatment from 16 weeks of age with 606A by a subcutaneously implanted osmotic pump, cardiac function, cardiac weight, acetylcholine-induced endothelium-dependent relaxation in the isolated aorta and renal function were estimated. Furthermore, wall thickness of the left ventricle was studied morphologically. We found that 606A (0.3 mg, 1 mg and 3 mg/head/day) dose-dependently lowered blood pressure without any effects on heart rate in SHRSP. Long-term treatments with 606A significantly reduced cardiac weight, left ventricular wall thickness and left ventricular end diastolic pressure, whereas it did not affect cardiac contractility. Endothelium-dependent relaxation of the aorta was recovered, and total protein excretion as well as t...Continue Reading
References
Oct 22, 1979·The American Journal of Cardiology·E D Frohlich, R C Tarazi
Jan 1, 1992·Life Sciences·K MizunoS Fukuchi
Apr 1, 1991·American Journal of Hypertension·F J FenoyR Roman
Apr 1, 1991·American Journal of Hypertension·K C BoveeM J Thoolen
Nov 1, 1991·Hypertension·A C Guyton
Nov 1, 1990·Hypertension·M ClozelF Hefti
Dec 1, 1990·Hypertension·T J ChildsA S Mak
Nov 1, 1990·Journal of Molecular and Cellular Cardiology·H G ZimmerG Mall
Jan 1, 1990·Drugs·C M Ferrario
Sep 1, 1990·Kidney International·M H XieM G Cogan
Jul 5, 1990·The New England Journal of Medicine·J A PanzaS E Epstein
Aug 15, 1989·Experientia·S SunanoK Shimamura
May 1, 1988·Pflügers Archiv : European journal of physiology·J Van de VoordeI Leusen
Jun 1, 1987·Hypertension·T F LüscherL Raij
Feb 1, 1987·Hypertension·T F LüscherP M Vanhoutte
Apr 1, 1982·European Heart Journal·R C TaraziP Khairallah
May 1, 1995·Biological & Pharmaceutical Bulletin·M IshiyeM Nakashima
Feb 1, 1995·Hypertension·G BruckschlegelH Schunkert
May 1, 1994·Hypertension·A D EverettR A Gomez
May 1, 1994·Circulation·M R TschudiT F Lüscher
Mar 1, 1996·Current Opinion in Nephrology and Hypertension·D B Johnson, L J Dell'Italia
Jun 1, 1996·British Journal of Pharmacology·S KimH Iwao
Aug 1, 1996·Journal of Cardiovascular Pharmacology·J P FauvelM Laville
Feb 1, 1997·Journal of Cardiovascular Pharmacology·Y HashimotoS Murata
Feb 1, 1997·Annals of Medicine·K HelinT Unger
Citations
Sep 20, 2000·Current Hypertension Reports·R Komers, S Anderson
Nov 7, 2002·Circulation Journal : Official Journal of the Japanese Circulation Society·Naoki IsobeHiroshi Kamiyama
Mar 24, 2009·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Daiju FukudaMasataka Sata
Dec 13, 2005·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Shinji TakaiMizuo Miyazaki
Dec 2, 1999·Japanese Journal of Pharmacology·Y HashimotoH Narita
Jul 2, 2003·Journal of Pharmacological Sciences·Fumiko SekiguchiSatoru Sunano
Feb 24, 2007·Journal of the Renin-angiotensin-aldosterone System : JRAAS·Vivencio BarriosRaúl Fernandez
Jun 17, 2000·Hypertension·H D Intengan, E L Schiffrin
Sep 1, 2007·Journal of Hypertension·Vivencio BarriosRaúl Fernandez
Aug 8, 2009·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Shinji TakaiMizuo Miyazaki
Mar 4, 2000·Journal of Hypertension·R KomersT Pelikanova
Apr 29, 1998·Journal of Cardiovascular Pharmacology·Y HashimotoS Murata